Automation News and Research

RSS

Advancing Precision Medicine in Argentina, Brazil and Chile – BGI Update

BGI Genomics recently participated in a mission business to South America in April 2023.

From BGI Genomics 16 May 2023

Creating the Lab of the Future; What does it entail?

As part of our SLAS US 2023 coverage, we speak to Luigi Da Via, Team Leader in Analytical Development at GSK, about the lab of the future, and what it may look like.

From Society for Laboratory Automation and Screening (SLAS) 15 May 2023

MGI's DNBSEQ-T20×2 wins BEYOND Healthcare Innovation Award

MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today is proud to announce that its DNBSEQ-T20×2 ("T20") gene sequencing platform has been awarded the BEYOND Healthcare Innovation Award.

From MGI 15 May 2023

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

Cellular Origins a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs).

From Cellular Origins 11 May 2023

What are the potential consequences of unchecked AI proliferation?

Research paper discusses the potential threats posed by artificial intelligence (AI) to human health and well-being, including control and manipulation of people, dehumanizing lethal weapon capacity, and rendering human labor obsolete. It also highlights the need for effective regulation and calls for a moratorium on the development of self-improving AI.

11 May 2023

Doctors and public health experts join the clamor for a moratorium on AI research

An international group of doctors and public health experts have joined the clamor for a moratorium on AI research until the development and use of the technology are properly regulated.

10 May 2023

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

...

From MGI 10 May 2023

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges

From Revvity 9 May 2023

Hamilton and Biosero Announce Co-Marketing Agreement to Optimize Automated Liquid Handling Workflows

Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing agreement aimed at streamlining automated liquid handling workflows. The partnership builds on Hamilton’s state-of-the-art automated platforms and Biosero’s innovative Green Button Go® Software Suite to increase lab efficiency.

From Biosero Inc. 9 May 2023

The Evolution of Molecular Biology

In this interview, Istvan Szatmari, the Head of The Genomic Core Facility at the Department of Biochemistry and Molecular Biology, talks to NewsMed about the evolution of Molecular Biology.

From MGI 4 May 2023

The African Personalized Medicine Agenda

In this interview, Rizwana Mia, the Senior Program Manager at South African Medical Research Council, talks to News Medical about the African personalized medicine agenda.

From MGI 4 May 2023

How the COVID pandemic has improved genomics

In this interview, Davide Cacchiarelli, Molecular Biology and Genomics Professor at the University of Naples talks to NewsMed about how the COVID pandemic has highlighted the vital role of genomic surveillance and improved genomics.

From MGI 4 May 2023

The Human Protein Atlas and Precision Medicine

In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.

From MGI 4 May 2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

From Gyros Protein Technologies AB 4 May 2023

Automation bias can affect the performance of radiologists when reading mammograms

Incorrect advice by an AI-based decision support system could seriously impair the performance of radiologists at every level of expertise when reading mammograms, according to a new study published in Radiology, a journal of the Radiological Society of North America.

3 May 2023

Paving the Way for New Drugs through Particle Perfection

Do particles hold the power to pave the way for new drugs? In this interview, we speak to Ben Knappett, head of science and applications at Particle Works to find out more!

From Society for Laboratory Automation and Screening (SLAS) 2 May 2023

MGI Announces New Customer Experience Center in South Korea with BMS

Cheonan, South Korea, 26 April 2023 – MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) in South Korea. In partnership with one of the country’s leading companies in life science technology, BMS (Bio-Medical science Co., Ltd.), the new CEC based in Cheonan aims to provide local customers and partners with the first-hand access to MGI's cutting-edge products.

From MGI 27 Apr 2023

Nanoparticles, mass spectrometry, and more – exploring new avenues for proteomics analysis

In this episode of omg OMx, Bruker's science-driven podcast, Kate Stumpo interviews Daniel Hornburg, the VP of Proteomics at Seer, as they discuss the innovative technologies in plasma proteomics. From nanoparticle-based enrichment to mass spec refinements, they explore how these tools facilitate unbiased, deep, and rapid proteomics.

From Bruker Life Sciences Mass Spectrometry 27 Apr 2023

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

To highlight how far the field of genetics has come, we spoke with Dr. Francis Collins, the leader of the Human Genome Project about his incredible career in genetics.

25 Apr 2023

Bioengineered drug candidate can counter S. aureus infection in early tests

Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.

24 Apr 2023

Automation News and Research

Advancing Precision Medicine in Argentina, Brazil and Chile – BGI Update

Creating the Lab of the Future; What does it entail?

MGI's DNBSEQ-T20×2 wins BEYOND Healthcare Innovation Award

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

What are the potential consequences of unchecked AI proliferation?

Doctors and public health experts join the clamor for a moratorium on AI research

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Hamilton and Biosero Announce Co-Marketing Agreement to Optimize Automated Liquid Handling Workflows

The Evolution of Molecular Biology

The African Personalized Medicine Agenda

How the COVID pandemic has improved genomics

The Human Protein Atlas and Precision Medicine

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Automation bias can affect the performance of radiologists when reading mammograms

Paving the Way for New Drugs through Particle Perfection

MGI Announces New Customer Experience Center in South Korea with BMS

Nanoparticles, mass spectrometry, and more – exploring new avenues for proteomics analysis

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

Bioengineered drug candidate can counter S. aureus infection in early tests

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News